Evidence map›Paper›PMID 19243222›Full record

ArticlePLoS biology2009

Obtaining consent for future research with induced pluripotent cells: opportunities and challenges.

Katriina Aalto-Setälä, Bruce R Conklin, Bernard Lo

Abstract read
In one paragraph

Article in PLoS biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Organoids: a systematic review of ethical issues.Stem cell research & therapy · 2022
    Pooled it
  2. Early-Phase Clinical Trials of Bio-Artificial Organ Technology: A Systematic Review of Ethical Issues.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Pooled it
  3. Pooled it
  4. Impact of non-welfare interests on willingness to donate to biobanks: an experimental survey.Journal of empirical research on human research ethics : JERHRE · 2014
    Trial
  5. Review
  6. Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models.International journal of molecular sciences · 2025
    Review
  7. Ethical frontiers in liver transplantation.World journal of transplantation · 2024
    Review
  8. Review
  9. Human brain organoid code of conduct.Frontiers in molecular medicine · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Developing cellular therapies for retinal degenerative diseases.Investigative ophthalmology & visual science · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katriina Aalto-SetäläGladstone Institute of Cardiovascular Disease, San Francisco, CA, USA.
Bruce R Conklin
Bernard Lo

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
NCRR NIH HHS 1 UL1-RR024131-01NCRR NIH HHS UL1 RR024131
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pluripotent Stem CellsBiomedical ResearchGuidelines as TopicHumansInformed ConsentPatient SelectionPrimary Health CareRandomized Controlled Trials as TopicResearch Design

Identifiers

PMID19243222
PMCPMC2652391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.